Sorry...link didn't work...Sire Bioscience Inc. Announces Letter of Intent to Acquire 100% of PlantFuel, Inc. MISSISSAUGA, Ontario, February 9, 2021 Sire Bioscience Inc. (CSE:SIRE) (OTC:BLLXF) (FSE:BR1B) (Sire or the Company) is pleased to announce that it has entered into a non-binding letter of intent (the LOI) to acquire 100% of Denver-based PlantFuel, Inc. (PlantFuel) for 65,000,000 common shares of the Company (the Common Shares), with an ascribed value of CAD$0.15 per common share, subject to due diligence, entering into a definitive agreement and other customary closing conditions, including the approval of the Canadian Securities Exchange. Under the proposed terms of the LOI, the management team at PlantFuel would continue on and the current shareholders of PlantFuel would have the right to nominate one additional member to the Board of Directors of the Company. Brian Polla, CEO, COO and a director of the Company commented: PLANTFUEL is a Science-Driven, Athlete-Focused, PLANT FUELED Nutrition Company. Its team is led by industry veterans who have driven companies in the nutraceutical and supplement spaces to over $1B in combined revenues. PlantFuel believes that rooted within the core of every athlete is the desire to improvebe it a drive to be stronger, faster, or healthier, the craving to Keep Going always endures. PlantFuels commitment to consumers is to create the best products available, to successfully bridge the gap between healthy, plant-based nutrition and peak performance. In pursuit of its quest to become the worlds first PLANT FUELED athlete-focused company, PlantFuel utilizes a multi-approach: a scientific process including world-class physician formulations, using clinically proven, banned substance-free ingredients that do not compromise on flavor, digestion quality, or performance output. 2500 Meadowpine Blvd. Unit 202, Mississauga, ON L5N 6C4 Ph: (416) 669-9392 Email: ir@sirebioscience.com www.sirebioscience.com NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN Sire Bioscience Inc. Announces Letter of Intent to Acquire 100% of PlantFuel, Inc. MISSISSAUGA, Ontario, February 9, 2021 Sire Bioscience Inc. (CSE:SIRE) (OTC:BLLXF) (FSE:BR1B) (Sire or the Company) is pleased to announce that it has entered into a non-binding letter of intent (the LOI) to acquire 100% of Denver-based PlantFuel, Inc. (PlantFuel) for 65,000,000 common shares of the Company (the Common Shares), with an ascribed value of CAD$0.15 per common share, subject to due diligence, entering into a definitive agreement and other customary closing conditions, including the approval of the Canadian Securities Exchange. Under the proposed terms of the LOI, the management team at PlantFuel would continue on and the current shareholders of PlantFuel would have the right to nominate one additional member to the Board of Directors of the Company. Brian Polla, CEO, COO and a director of the Company commented: PLANTFUEL is a Science-Driven, Athlete-Focused, PLANT FUELED Nutrition Company. Its team is led by industry veterans who have driven companies in the nutraceutical and supplement spaces to over $1B in combined revenues. PlantFuel believes that rooted within the core of every athlete is the desire to improvebe it a drive to be stronger, faster, or healthier, the craving to Keep Going always endures. PlantFuels commitment to consumers is to create the best products available, to successfully bridge the gap between healthy, plant-based nutrition and peak performance. In pursuit of its quest to become the worlds first PLANT FUELED athlete-focused company, PlantFuel utilizes a multi-approach: a scientific process including world-class physician formulations, using clinically proven, banned substance-free ingredients that do not compromise on flavor, digestion quality, or performance output.